- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Erich Mounce: Providing Relevant Data to Provider Practices Encourages Growth
Providing providers with relevant data on quality of care and profitability allows them to adjust their practices efficiently, said Erich Mounce, chief operating officer, OneOncology.
Providing providers with relevant data on quality of care and profitability allows them to adjust their practices efficiently, said Erich Mounce, chief operating officer, OneOncology.
Transcript
If a practice isn’t doing well on cost savings or achieving high-quality care, how does OneOncology approach adjusting provider practices?
Well, I think the beauty of OneOncology is it’s not this cookbook process. It’s not—here’s our only way to do it and if you don’t do it this way, we come hit you with a club. I think it’s a variation of themes. We’ve got some practices—they’re really restrict regimens. We have some practices that have a little bit more selection of preferred regimens. It’s an education process and a rapid learning cycle of how that data is recirculated back. So, the first thing we do is sort of measure where they are and then start to feedback data. Then we also show them if they would adhere a little bit more to this pathway or perform a little bit better under this contract, look how that will affect either your compensation or profitability. So, it’s really taking all of that data, and constantly feeding back accurately and allowing the doctors to buy into that. That really does tend to move physician behavior a lot more than us just saying; you guys aren’t doing well—you need to do it this way.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More
